BACKGROUND Innate immune responses activated through myeloid cells contribute to the initiation, progression, and
Direct interactions between scavenger receptors involved in lipid body formation (e.g., CD36), and TLR involved in the induction of inflammatory responses (e.g., TLR2, TLR4, and TLR6) have been identified (10, 11) and proposed to play a role in this process (11) . However, the independent in vivo impact of such pathways on lesion development and the accumulation of proinflammatory foamy macrophages remains modest. For example, deletion of [TNF]-a, IL-1b) while it inhibits the release of antiinflammatory IL-10 (16). TREM-1 also regulates monocyte and neutrophil migration to inflammatory sites (15, 17) . TREM-1 has been studied mainly during septic shock, but it also is critical during aseptic inflammation in both acute (pancreatitis) (18) and chronic (rheumatoid arthritis) conditions (19) . A recently designed dodecapeptide named LR12 (LQEE-DAGEYGCM), derived from TREM-1-like transcript 1, strongly inhibits TREM-1 engagement by competing with its still unknown endogenous ligand. LR12 modulates the innate immune response following bacterial aggression in rodents (20) , pigs (21) , and primates (22) , translating into an attenuation of organ dysfunction and improved outcome (20, 21) . We recently reported that TREM-1 is involved is post-ischemic myocardial remodeling by orchestrating leukocyte recruitment to the ischemic heart and subsequent inflammatory responses (23) . Additionally, in a multicenter cohort of patients with acute coronary syndromes, we showed that plasma TREM-1 level was an independent predictor of major adverse cardiovascular events (23) .
Here, we evaluated the effects of TREM-1 in murine monocytes/macrophages on inflammatory cell activation, trafficking, and foam cell formation to assess TREM-1 as an upstream target in atherosclerosis. Joffre et al.
D E C E M B E R 2 7 , 2 0 1 6 : 2 7 7 6 -9 3 EXTENT AND COMPOSITION OF ATHEROSCLEROTIC LESIONS. Plasma cholesterol was measured using a commercial cholesterol kit. Quantification of lesion size was performed as described previously (27) .
Briefly, the basal half of the ventricles and ascending aorta were perfusion-fixed in situ with 4% paraformaldehyde. Afterward, they were removed, Collagen was detected using Sirius red stain, and necrotic core was quantified after Masson's trichrome staining. Macrophage presence was determined using specific antibodies, as previously described (29 were considered significant at a p value of <0.05.
RESULTS
To address the role of myeloid Trem-1 in the development of atherosclerosis, we performed bone marrow transplantation experiments using either suggesting that other mechanisms prevail. We then tested the possibility that Trem-1 controls monocyte
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TREM-1 Inhibition Reduces Atherosclerosis 
In Ldlr À/À mice, Trem-1 deficiency in myeloid cells reduced development of atherosclerosis and induced a stable plaque phenotype. As seen in flow cytometry in blood leukocytes gated on CD11bþCD115high monocytes, TREM-1 was expressed by nonclassical Gr1 low monocytes in the control (Ldlr other abbreviations as in Figure 1 .
Joffre et al. mice after 6 weeks of fat diet ( Figures 2M and 2N) . Joffre et al.
D E C E M B E R 2 7 , 2 0 1 6 : 2 7 7 6 -9 3 Figure 11C ) in the lesions, but had no effect on T cell infiltration (Online Figure 11D ) or collagen content (Online Figure 11E) . To Figure 7I ) and a few neutrophils (Online Figure 13A ) but was not detected in a-actin þ SMCs ( Figure 7J ) or CD3 þ T cells (Online Figure 13B) .
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We quantified TREM-1 protein levels in human plaque extracts obtained after endarterectomy (Online Figure 14) and found TREM-1 expression was significantly higher in atheromatous lesions than in fibrous lesions (p ¼ 0.002) ( Figure 7K ).
DISCUSSION
Using 3 complementary approaches, we found that TREM-1 deficiency/inhibition significantly reduced atherosclerosis growth in mice and induced a less inflammatory plaque phenotype characterized by reduced macrophage infiltration and necrotic core size. It is interesting to note that TREM-1 deletion or blockade was associated with significant and profound (up to 60%) reduction of the development of both early and advanced atherosclerosis and the protective effect was observed throughout the aorta 
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(aortic sinus, ascending, and descending aorta). This We also showed that TREM-1 Joffre et al.
was expressed in advanced human atherosclerotic lesions, mostly close to cholesterol-rich and necroticrich areas, and its expression was significantly higher in atheromatous lesions.
TREM-1 is highly conserved during evolution (37) and expressed mainly by bone marrow-derived leukocytes (15 
